R&D Tax Credit Advance Funding UK
Market Invoice is an independent UK invoice finance comparison site that lists 87 UK invoice finance companies in its directory (69 lenders trading) and has 18 in its Rate Index.
HMRC can take several weeks to pay an R&D tax credit claim, and longer if it opens a check. Some lenders will lend against the claim so you get the cash sooner, and they are repaid when HMRC pays. Two lenders we checked on their own websites on 14 October 2026 offer this: Fundsquire and SPRK Capital. Neither publishes a fee or advance rate on the pages we read, so every advance is quoted per claim. It suits R&D-heavy businesses (software, biotech, engineering) that have already spent the money and are waiting on a claim.
What this page covers
Covered here:
R&D tax credit advance funding UK: how it works, how to compare the cost, lenders that offer it, what to check.
Not covered here:
general invoice finance education (see UK Invoice Finance Guides), individual provider reviews (see UK invoice finance companies), full pricing breakdown (see Invoice Finance Costs)
Lenders that offer R&D tax credit advances
| Lender | Fee | What its own website says |
|---|---|---|
| Fundsquire | Not published | An R&D tax credit loan "allows a company to use its future R&D tax credit payments as collateral" for a loan, for companies in the SME scheme. Source |
| SPRK Capital | Not published | "A dedicated lender to businesses engaged in innovation", offering R&D tax credit loans repaid when HMRC pays. Source |
Checked on each lender's own website on 14 October 2026. This is not a full list. Market Invoice is not connected to either lender. Get at least two quotes before signing.
The R&D claim timeline, and where the gap comes from
An R&D tax credit claim is filed with HMRC through your company tax return, usually prepared by your accountant or a claim specialist. HMRC usually takes several weeks to process a claim, and claims picked for a compliance check can take much longer. For an R&D-heavy business the money is often already spent, on salaries, contractors and cloud costs, so the wait is a runway problem: the credit is near-certain money arriving on an uncertain date. Advance funding exists purely to bridge that window.
Who advances against R&D claims
Some lenders make R&D advances a core product, such as the two named above. Some R&D claim advisers also offer or arrange funding linked to the claims they prepare. The amount, fee and checks vary with the claim size, the scheme and how strong the claim looks, so treat the first quote as one data point: get at least two, and ask whether the lender needs the claim to be prepared by an adviser it knows.
How the cash advance process works
The mechanics run in five steps. First, the claim is submitted to HMRC. Second, you apply to the lender with the submitted claim value and supporting computation. Third, the lender lends an agreed share of the expected credit once its checks are done. Fourth, HMRC processes the claim and pays into a nominated account under the lender's control.
Fifth, the lender deducts its principal and fee and releases the balance to you. Some lenders will consider an advance before submission where the R&D activity is well documented, but that is rarer, costs more, and involves heavier underwriting.
Claim sizes that make sense to advance
Each lender sets its own minimum and maximum claim size, and the two named above do not publish one on the pages we read. On a small claim the fee and checks can cost more than the wait is worth, and a short overdraft or director loan may be cheaper. On a very large claim, a different kind of loan may price better. Ask each lender for its limits before you apply.
Cost vs waiting, and cost vs equity
Fees are quoted per claim, and the two lenders above do not publish them. Turn any quote into a yearly rate to compare it. For example, a 6 percent fee on money you would otherwise have waited about 60 days for works out at about 36 percent a year. The honest comparison is not against a bank loan, though, but against the alternatives actually available in the window: missing payroll, pausing hiring, or raising equity earlier than planned.
Against dilution at an early-stage valuation, a single-cycle fee on a near-certain receivable is often the cheaper option. What it should never become is a rolling, every-quarter funding strategy; if you need it every cycle, the underlying problem is working capital, and a standard facility will price better.
Founder & Managing Director, Muswell Rose, founder and PSC of Best Business Loans Ltd
Adam was managing director of Penny, a UK invoice finance business, from July 2020 to November 2023. His career runs through insurance, mortgages, commercial finance and fintech lending. He writes the Market Invoice library. Career record.
Last updated: